Book contents
- Stahl’s Self-Assessment Examination in Psychiatry
- Stahl’s Self-Assessment Examination in Psychiatry
- Copyright page
- Contents
- Introduction/Preface
- CME Information
- 1 Basic Neuroscience
- 2 Psychosis and Schizophrenia and Antipsychotics
- 3 Unipolar Depression and Antidepressants
- 4 Bipolar Disorder and Mood Stabilizers
- 5 Anxiety Disorders and Anxiolytics
- 6 Chronic Pain and its Treatment
- 7 Disorders of Sleep and Wakefulness and Their Treatment
- 8 Attention Deficit Hyperactivity Disorder (ADHD) and its Treatment
- 9 Dementia and Cognitive Function and its Treatment
- 10 Substance Use and Impulsive Compulsive Disorders and their Treatment
- Optional Posttests and CME Certificates
- Index
- References
5 - Anxiety Disorders and Anxiolytics
Published online by Cambridge University Press: 19 October 2021
Book contents
- Stahl’s Self-Assessment Examination in Psychiatry
- Stahl’s Self-Assessment Examination in Psychiatry
- Copyright page
- Contents
- Introduction/Preface
- CME Information
- 1 Basic Neuroscience
- 2 Psychosis and Schizophrenia and Antipsychotics
- 3 Unipolar Depression and Antidepressants
- 4 Bipolar Disorder and Mood Stabilizers
- 5 Anxiety Disorders and Anxiolytics
- 6 Chronic Pain and its Treatment
- 7 Disorders of Sleep and Wakefulness and Their Treatment
- 8 Attention Deficit Hyperactivity Disorder (ADHD) and its Treatment
- 9 Dementia and Cognitive Function and its Treatment
- 10 Substance Use and Impulsive Compulsive Disorders and their Treatment
- Optional Posttests and CME Certificates
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Stahl's Self-Assessment Examination in PsychiatryMultiple Choice Questions for Clinicians, pp. 197 - 232Publisher: Cambridge University PressPrint publication year: 2019
References
References
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013.1Google Scholar
Stahl, SM, Grady, MM. Stahl’s illustrated anxiety, stress, and PTSD. New York, NY: Cambridge University Press; 2010.2Google Scholar
References
Kandel, ER, Schwartz, JH, Jessell, TM, Siegelbaum, SA, Hudspeth, AJ. Principles of neural science, fifth edition. Columbus, OH: McGraw-Hill Education; 2012.1Google Scholar
Shin, LM, Liberzon, I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010;35(1): 169–91.2Google Scholar
Steimer, T. The biology of fear- and anxiety-related behaviors. Dialogues Clin Neurosci 2002;4(3):231–49.3Google Scholar
References
Bremner, JD. Stress and brain atrophy. CNS Neurol Disord Drug Targets 2006;5(5):503–12.1Google ScholarPubMed
Stahl, SM, Grady, MM. Stahl’s illustrated anxiety, stress, and PTSD. New York, NY: Cambridge University Press; 2010.2Google Scholar
References
Sauve, W, Stahl, SM. Psychopharmacological treatment of PTSD. In: Treating PTSD in military personnel: a clinical handbook. New York, NY: Guilford Press; 2011.1Google Scholar
Stahl, SM. Case studies: Stahl’s essential psychopharmacology. New York, NY: Cambridge University Press; 2011.2CrossRefGoogle Scholar
Stahl, SM, Grady, MM. Stahl’s illustrated anxiety, stress, and PTSD. New York, NY: Cambridge University Press; 2010.3Google Scholar
References
Stahl, SM. Stahl’s essential psychopharmacology: the prescriber’s guide, sixth edition. New York, NY: Cambridge University Press; 2017.1Google Scholar
References
Stahl, SM. Stahl’s essential psychopharmacology: the prescriber’s guide, sixth edition. New York, NY: Cambridge University Press; 2017 1.Google Scholar
References
Korosi, A, Baram, TZ. Plasticity of the stress response early in life: mechanisms and significance. Dev Psychobiol 2010;52:661–70.1Google Scholar
McClelland, S, Korosi, A, Cope, J, Ivy, A, Baram, TZ. Emerging roles of epigenetic mechanisms in the enduring effects of early-life stress and experience on learning and memory. Neurobiol Learning Mem 2011;96(1):79–88.2Google Scholar
References
Orr, SP, Milad, MR, Metzger, LJ, Lasko, NB, Gilbertson, MW, Pitman, RK. Effects of beta blockade, PTSD diagnosis, and explicit threat on the extinction and retention of an aversively conditioned response. Biol Psychol 2006;732:262–71.1Google Scholar
Sauve, W, Stahl, SM. Psychopharmacological treatment of PTSD. In: Treating PTSD in military personnel: a clinical handbook. New York, NY: Guilford Press; 2011.2Google Scholar
Stahl, SM. Case studies: Stahl’s essential psychopharmacology. New York, NY: Cambridge University Press; 2011.3CrossRefGoogle Scholar
Stahl, SM, Grady, MM. Stahl’s illustrated anxiety, stress, and PTSD. New York, NY: Cambridge University Press; 2010.4Google Scholar
References
Nuss, P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat 2015;11:165–75.1Google ScholarPubMed
Stahl, SM. Selective actions on sleep or anxiety by exploiting GABA-A/benzodiazepine receptor subtypes. J Clin Psychiatry 2002;63(3):179–80.2Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013.3Google Scholar
References
Forneris, CA, Gartlehner, G, Brownley, KA, et al. Interventions to prevent post-traumatic stress disorder: a systematic review. Am J Prev Med 2013;44(6):635–50.1CrossRefGoogle ScholarPubMed
Kliem, S, Kroger, C. Prevention of chronic PTSD with early cognitive behavioral therapy. A metaanalysis using mixed-effects modeling. Behav Res Ther 2013;51(11):753–61.2Google Scholar
Stahl, SM, Grady, MM. Stahl’s illustrated anxiety, stress, and PTSD. New York, NY: Cambridge University Press; 2010.3Google Scholar
Zayfert, C, Becker, CB. Cognitive-behavioral therapy for PTSD: a case formulation approach. New York, NY: The Guildford Press; 2007.4Google Scholar
References
Management of Posttraumatic Stress Disorder Work Group. VA/DOD Clinical practice guideline: the management of posttraumatic stress disorder and acute stress reaction 2017. Washington DC; Department of Defense, 2017.1Google Scholar
Roberts, NP, Roberts, PA, Jones, N, Bisson, JI. Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: a systematic review and meta-analysis. Clin Psychol Rev 2015;38:25–38.2CrossRefGoogle ScholarPubMed
Stahl, SM, Grady, MM. Stahl’s illustrated anxiety, stress, and PTSD. New York, NY: Cambridge University Press; 2010.3Google Scholar
Zandberg, LJ, Rosenfield, D, Mclean, CP, Powers, MB, Asnaani, A, Foa, EB. Concurrent treatment of posttraumatic stress disorder and alcohol dependence: predictors and moderators of outcome. J Consult Clin Psychol 2016;84(1):43–56.4CrossRefGoogle ScholarPubMed
References
Abudy, A, Juven-Wetzler, A, Zohar, J. Pharmacological management of treatment-resistant obsessive-compulsive disorder. CNS Drugs 2011;25(7):585–96.1Google Scholar
References
Manfredi, RL, Kales, A, Vgontzas, AN, Bixler, EO, Isaac, MA, Falcone, CM. Buspirone: sedative or stimulant effect? Am J Psychiatry 1991;148(9):1213–7.1Google Scholar
Ramboz, S, Oosting, R, Amara, DA, et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 1998;95(24):14476–81.2Google Scholar
Piszczek, L, Piszczek, A, Kuczmanska, J, Audero, E, Gross, CT. Modulation of anxiety by cortical serotonin 1A receptors. Front Behav Neurosci 2015;9: 48.3Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fourth edition. New York, NY: Cambridge University Press; 2013.4Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology: the prescriber’s guide, sixth edition. New York, NY: Cambridge University Press; 2017.5Google Scholar
References
Kung, A, Espinel, Z, Lalpid, MI. Treatment of nightmares with prazosin: a systematic review. Mayo Clin Proc 2012;87(9):890–900.1Google Scholar
Simon, PY, Rousseau, PF. Treatment of post-traumatic stress disorders with the alpha-1 adrenergic antagonist prazosin. Can J Psychiatry 2017;62(3):186–98.2Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology: the prescriber’s guide, sixth edition. New York, NY: Cambridge University Press; 2017.3Google Scholar
References
Feder, A, Parides, MK, Murrough, JW et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 2014;71(6):681–8.1Google Scholar
Womble, AL. Effects of ketamine on major depressive disorder in a patient with posttraumatic stress disorder. AANA J 2013;81(2):118–9.2Google Scholar
References
Gentile, S. Tricyclic antidepressants in pregnancy and puerperium. Expert Opin Drug Saf 2014;13:207–25.1Google Scholar
Grover, S, Avasthi, A, Sharma, Y. Psychotropics in pregnancy: weighing the risks. Indian J Med Res 2006;123(4):497–512.2Google Scholar
Goodman, JH, Chenausky, KL, Freeman, MP. Anxiety disorders during pregnancy: a systematic review. J Clin Psychiatry 2014;75(10):e1153–84.3CrossRefGoogle ScholarPubMed
Marchesi, C, Ossola, P, Amerio, A, Daniel, BD, Tonna, M, De Panfilis, C. Clinical management of perinatal anxiety disorders: a systematic review. J Affect Disord 2016;190:543–50.4CrossRefGoogle ScholarPubMed
Myles, N, Newall, H, Ward, H, Large, M. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations. Aust N Z J Psychiatry 2013;47:1002–12.5Google Scholar
Ram, D, Gandotra, S. Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation. Indian J Psychiatry 2015;57(Suppl 2):S354–71.6Google ScholarPubMed
Reefhuis, J, Devine, O, Friedman, JM, Louik, C, Honein, MA. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports. BMJ 2015;351:h3190.7CrossRefGoogle ScholarPubMed
Yonkers, KA, Wisner, KL, Stewart, DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry 2009;31:403–13.8CrossRefGoogle ScholarPubMed